Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Early Phase 1
1(100.0%)
1Total
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04916132Recruiting

Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors

Role: collaborator

NCT04043585Completed

Bariatric Surgery on NASH

Role: collaborator

NCT04043065Early Phase 1Completed

Liver-enriched Antimicrobial Peptide 2

Role: collaborator

All 3 trials loaded